Idexx Laboratories (IDXX) shares outstanding: 78.8M
Idexx Laboratories had 78.8M shares outstanding on Oct 28, 2026, down 1.3% from 79.9M a year earlier.
From Idexx Laboratories's filings with the SEC · IDXX stock page
Idexx Laboratories shares outstanding by year
#1,489 of 3,715 US companies by shares outstanding · See the full ranking
| Year ended | Shares outstanding | Change |
|---|---|---|
| Oct 28, 2026 | 78.8M | -1% |
| Oct 29, 2025 | 79.9M | -2% |
| Oct 28, 2024 | 81.9M | -1% |
| Oct 27, 2023 | 83.1M | +0% |
| Oct 28, 2022 | 82.8M | – |
Shares outstanding of similar companies
Companies in the same industry as Idexx Laboratories, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.
| Company | Shares outstanding, latest year | Year ended |
|---|---|---|
| Neogen | 218.3M | Aug 31, 2026 |
| Intellia Therapeutics | 140.4M | Oct 30, 2026 |
| Achieve Life Sciences | 110.0M | Nov 10, 2026 |
| Idexx Laboratories | 78.8M | Oct 28, 2026 |
| Celldex Therapeutics | 78.5M | Oct 28, 2026 |
| QuidelOrtho | 68.6M | Oct 28, 2026 |
| Lantheus Holdings | 65.4M | Nov 2, 2026 |
Questions and answers
What is Idexx Laboratories's shares outstanding?
Idexx Laboratories had 78.8M shares outstanding on Oct 28, 2026, down 1.3% from 79.9M a year earlier.
Numbers as reported in Idexx Laboratories's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology